MARK TURRENTINE to Cost-Benefit Analysis
This is a "connection" page, showing publications MARK TURRENTINE has written about Cost-Benefit Analysis.
Connection Strength
0.294
-
Response to Letter. Obstet Gynecol. 2020 08; 136(2):429-430.
Score: 0.149
-
Cost Effectiveness of Latest Recommendations for Group B Streptococci Screening in the United States. Obstet Gynecol. 2020 04; 135(4):789-798.
Score: 0.145